Raschi, Emanuel

Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems

Cutroneo, P. M., Sartori, D., Tuccori, M., Crisafulli, S., Battini, V., Carnovale, C., Rafaniello, C., Capuano, A., Poluzzi, E., Moretti, U., et al. (2024) · Frontiers in Drug Safety and Regulation

Pharmacovigilance and Adverse Drug ReactionsStatistical Methods in Clinical Trials

Cited by 224

Lessons to be learnt from real-world studies on immune-related adverse events with checkpoint inhibitors: a clinical perspective from pharmacovigilance

Raschi, E., Gatti, M., Gelsomino, F., Ardizzoni, A., Poluzzi, E., & De Ponti, F. (2020) · Targeted Oncology

Cancer Immunotherapy and BiomarkersPharmacovigilance and Adverse Drug Reactions

Cited by 157

Post-Marketing Safety Concerns with Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System

Gastaldon, C., Raschi, E., Kane, J. M., Barbui, C., & Schoretsanitis, G. (2021) · Psychotherapy and Psychosomatics

Pharmacovigilance and Adverse Drug ReactionsTreatment of Major Depression

Cited by 134

Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: what a clinician should know on disproportionality analysis of spontaneous reporting systems

Raschi, E., Poluzzi, E., Salvo, F., Pariente, A., De Ponti, F., Marchesini, G., & Moretti, U. (2018) · Nutrition, Metabolism and Cardiovascular Diseases

Pharmacovigilance and Adverse Drug ReactionsDiabetes Treatment and Management

Cited by 119

Disproportionality Analysis From World Health Organization Data on Semaglutide, Liraglutide, and Suicidality

Schoretsanitis, G., Weiler, S., Barbui, C., Raschi, E., & Gastaldon, C. (2024) · JAMA Network Open

Pharmacovigilance and Adverse Drug ReactionsSuicide and Self-Harm Studies

Cited by 107

Toxicities with immune checkpoint inhibitors: emerging priorities from disproportionality analysis of the FDA adverse event reporting system

Raschi, E., Mazzarella, A., Antonazzo, I. C., Bendinelli, N., Forcesi, E., Tuccori, M., Moretti, U., Poluzzi, E., & De Ponti, F. (2019) · Targeted Oncology

Cancer Immunotherapy and BiomarkersPharmacovigilance and Adverse Drug Reactions

Cited by 101

Sudden cardiac and sudden unexpected death related to antipsychotics: A meta-analysis of observational studies

Salvo, F., Pariente, A., Shakir, S., Robinson, P., Arnaud, M., Thomas, S., Raschi, E., Fourrier‐Réglat, A., Moore, N., Sturkenboom, M., et al. (2016) · Clinical Pharmacology & Therapeutics

Cardiac electrophysiology and arrhythmiasSchizophrenia research and treatment

Cited by 83

Adverse reactions to dietary supplements containing red yeast rice: assessment of cases from the Italian surveillance system

Mazzanti, G., Moro, P. A., Raschi, E., Da Cas, R., & Menniti‐Ippolito, F. (2017) · British Journal of Clinical Pharmacology

Complementary and Alternative Medicine StudiesPharmacovigilance and Adverse Drug Reactions

Cited by 81

Hepatitis B vaccination and the putative risk of central demyelinating diseases – a systematic review and meta-analysis.

Mouchet, J., Salvo, F., Raschi, E., Poluzzi, E., Antonazzo, I. C., De Ponti, F., & Bégaud, B. (2018) · Vaccine

Multiple Sclerosis Research StudiesHepatitis B Virus Studies

Cited by 49

The Changing Face of Drug-induced Adrenal Insufficiency in the Food and Drug Administration Adverse Event Reporting System

Raschi, E., Fusaroli, M., Massari, F., Mollica, V., Repaci, A., Ardizzoni, A., Poluzzi, E., Pagotto, U., & Di Dalmazi, G. (2022) · The Journal of Clinical Endocrinology & Metabolism

Pharmacovigilance and Adverse Drug ReactionsAdrenal Hormones and Disorders

Cited by 17